KTH-222

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameKTH-222
Drug Alias NameKTH-222
ClassificationSmall molecules
Mechanisms of ActionTubulin inhibitorsMitogen-activated protein kinase inhibitors
TargetsMitogen-activated protein kinaseTubulin
Therapy Area/IndicationsProstatic NeoplasmsOvarian NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKalos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOncology Pharma IncKalos Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsOvarian NeoplasmsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A